All News

    Novel Drug Elicits Favorable Outcomes in Advanced, Metastatic TNBC

    December 10th 2021

    Early-phase study results showed that treatment with a novel drug elicits promising outcomes in patients with advanced or metastatic triple-negative breast cancer.

    Immunotherapy Before Surgery May ‘Increase the Chances’ Patients Are Cured of TNBC

    December 9th 2021

    Clinical trial results show that adding Keytruda to chemotherapy prior to surgery for triple-negative breast cancer can improve outcomes and hopefully “increase the chances for patients to be cured,” according to an expert.

    Black Patients More Likely to Experience Treatment Changes That May Worsen Breast Cancer Outcomes

    December 9th 2021

    Treatment modifications in the pre-surgery setting led to a lower rate of pathologic complete response in Black patients with breast cancer, the researchers found.

    The Holidays Can Be Bittersweet for Cancer Survivors: Here’s How I’m Riding Out the Waves

    December 9th 2021

    Oftentimes the warmest holiday moments can remind cancer survivors of how much their paths have been derailed, a survivor explains.

    ‘Cancer Fashionista’ Discusses Finding Confidence During Cancer

    December 9th 2021

    On this episode of the “Cancer Horizons” podcast, a woman with multiple myeloma shares how she made the best of her cancer treatment process by channeling her emotions through fashion expression.

    CURE® Celebrates Eight Individuals’ Contributions at the 9th Annual MPN Heroes Program

    December 9th 2021

    CURE®’s ninth annual MPN Heroes Program recognized the heroes who go above and beyond to support patients with the disease.

    Study Confirms Adding Ibrance to Endocrine Therapy May Not Improve Outcomes in Early Breast Cancer

    December 8th 2021

    The addition of Ibrance to endocrine therapy was not associated with preventing disease recurrence in patients with hormone receptor (HR)–positive, human epidermal growth factor receptor 2 (HER2)–negative early breast cancer, according to final results of the phase 3 PALLAS trial.

    FDA Clears Amma, a Scalp-Cooling Device to Prevent Chemo-Related Hair Loss in Patients With Cancer

    December 8th 2021

    Amma was developed by a cancer survivor who wanted an easier — and cheaper — way for patients to preserve their hair during chemotherapy treatment.

    Heal at Home: 3 Simple Recipes That Patients With Cancer, Others Can Make to Wow at Their Holiday Parties

    December 8th 2021

    CURE®’s second episode of its cooking show, Heal at Home, is here! And this time, we are bringing cancer survivors, patients and their loved ones the nutrition with a dash of holiday cheer.

    As a Cancer Survivor, the COVID-19 Omicron Variant Makes Me Want to Scream

    December 8th 2021

    Each time a new COVID-19 variant takes the world by storm, cancer survivors struggle to cope with the resulting exhaustion and fear, one survivor explains.

    Medication Used to Treat Diabetes Fails to Improve Breast Cancer Outcomes

    December 8th 2021

    Researchers hypothesized that metformin — a medication that helps lower insulin levels in patients with diabetes and is associated with inducing weight loss — might improve breast cancer outcomes.

    Novel Drug Has Potential to ‘Become New Standard of Care’ in Advanced, ER-Positive Breast Cancer

    December 8th 2021

    The use of elacestrant, an investigational therapy, elicited a 30% reduction in the risk of disease progression or death compared with standard of care in a group of patients with estrogen receptor (ER)–positive, HER2-negative metastatic breast cancer.

    Novel Drug Combo Doubles Progression-Free Survival in HER2-Negative Metastatic Breast Cancer

    December 7th 2021

    Ibrance plus Faslodex improved progression-free survival in certain patients with metastatic breast cancer, compared with those who continued to receive an aromatase inhibitor.

    Geriatric Assessments May Open the Door to High-Quality Conversations About Frailty and Aging-Related Concerns in Older Patients With Advanced Cancer

    December 7th 2021

    Frail patients older than 70 years who underwent geriatric assessment and received pertinent advice related to those results were more likely to have high-quality conversations with their oncologists about age-related concerns like physical activity and cognition.

    Why I View the Cancer Treatment-Related Changes of My Body With Humor

    December 7th 2021

    An ovarian cancer survivor describes the changes her body endured after treatment and explains why she chooses to laugh at them.

    Black Women With Breast Cancer Have a Higher Risk of Developing Lymphedema Than White Women

    December 7th 2021

    Black race is associated with a 3.5-fold increased incidence of lymphedema in women with breast cancer treated with axillary lymph node dissection and radiotherapy, according to recent data.

    CURE® Honors Patients, Advocates, Oncologist in Inaugural Metastatic Breast Cancer Heroes™ Award Program for Increasing Awareness

    December 7th 2021

    CURE’s Metastatic Breast Cancer Heroes™ Award Program expresses gratitude to the heroes who impact the lives of patients with metastatic breast cancer.

    CURE Remembers MJH Life Sciences Founder Michael J. Hennessy

    December 6th 2021

    Hennessy, 61, founded MJH Life Sciences, the publisher of CURE Magazine, more than 20 years ago.

    Combination Immunotherapy Helps Patients With Kidney Cancer Live Longer and ‘Get Back to Their Regular Lives’

    December 6th 2021

    Treatment-free survival with Opdivo and Yervoy was more than twice as long when compared with Sutent alone in patients with kidney cancer.

    What a Mother of a Cancer Survivor Really Wants for Christmas

    December 6th 2021

    A mother of a young breast cancer survivor shares the letter she wrote to Santa explaining her only Christmas wish.

    The Ins and Outs of Risk Stratification, Managing Side Effects and Survivorship in Breast Cancer

    December 6th 2021

    Patients who understand their roles and responsibilities may better help their care teams understand what they may be at risk for in their cancer survivorship.

    Prior Successful Coping Strategies May Help Manage Cancer-Related Stress

    December 6th 2021

    People who have successfully navigated difficult times in the past may be able to use those previous coping strategies to help them weather new stress related to a cancer diagnosis, treatment or survivorship, according to an expert from the George Washington University Cancer Center.

    The Multi-Billion-Dollar Business Behind Cancer: Why Is it a Commodity?

    December 5th 2021

    A male breast cancer survivor takes a critical look at the confusing marketing campaigns that surround his disease.

    My Dear Friend and Cancer ‘Warrior’ Refuses to Fold

    December 5th 2021

    A cancer survivor describes an inspiring close friend who has been dealing with cancer for 13 years and refuses to give up.

    Why a Piece of Paper Is a Cancer Survivor’s Most Prized Possession

    December 4th 2021

    A cancer survivor explains how her most prized possession went from being a faux fur coat to the slip of paper that reads, “No cancer detected.”

    The Superhero Oncologist Who Saved My Friend From Cancer

    December 4th 2021

    A woman explains how her close friend achieved remission from stage 4 lung cancer after being treated by Dr. Bret Friday – a superhero in her book.

    Bayer Announces Combination Therapy With Nubeqa May Improve Survival in Metastatic Prostate Cancer Subset

    December 3rd 2021

    The pharmaceutical company announced preliminary results on a phase 3 trial, which demonstrated that Nubeqa with docetaxel and androgen deprivation therapy may improve overall survival in men with metastatic hormone-sensitive prostate cancer.

    Surviving My 'Cancerversaries' Reminds Me of Those I Have Lost

    December 3rd 2021

    Cancerversaries can stir up difficult emotions for many cancer survivors. One pancreatic cancer survivor offers advice on how to cope with these feelings.

    FDA Approves Rituxan-Chemotherapy Combo for Children with a Variety of Blood Cancers

    December 3rd 2021

    The FDA approval of Rituxan plus chemotherapy is indicated for the treatment of children aged six months to 18 years who have various forms of lymphoma or a form of leukemia.

    Kathy Griffin Is Cancer-Free, Michael Bublé Opens Up About Son’s Cancer and More

    December 3rd 2021

    From Kathy Griffin sharing that she is now cancer free to Michael Bublé discussing his son’s cancer journey, here’s what’s happening in the cancer landscape this week.

    NEXT PAGE
    PREVIOUS PAGE